FDA releases details of Gilead violations; Cardinal grabs China distributor for $470M;

@FiercePharma: The Best of FiercePharma 2010. Report | Follow @FiercePharma

> The FDA has released the details of its inspection of Gilead Sciences' San Dimas, California, plant in January and February, identifying ongoing problems with quality-control procedures at the facility. Report

> U.S. drug wholesaler Cardinal Health said it has bought a Chinese distributor for $470 million, establishing a foothold in a booming pharmaceutical market. Cardinal Health release | News

Special Report: Top 10 Medical Device Companies: 2010. Report

> GlaxoSmithKline is seeking to defend the patent on its top-selling lung drug Advair in a Dutch court in the latest in a series of legal skirmishes across Europe over the inhaled medicine. Article

> Otsuka Holdings, Japan's largest closely held drugmaker, told investors it will use proceeds from an initial public offering to buy drug and health-food businesses, sources told Bloomberg. Story

> Novartis has failed to convince the U.K.'s cost-effectiveness watchdog that its revised patient access scheme for Afinitor would make the kidney cancer drug a smart choice for use by the National Health Service. Item 

Special Report: The Big 3 Distributors. Report  

> There are signs that outsourcing in the pharmaceutical sector is staging a comeback after a couple of tough operating years, sector specialist Jim Miller said at the American Association of Pharmaceutical Sciences (AAPS) annual meeting. News

> A chemical found in the varnish coating of pharmaceutical bottles has been shown to migrate into the contents and be deposited on tablets carried within. Report

Biotech News

 @FierceBiotech: The Best of FierceBiotech 2010. Report | Follow @FierceBiotech

> Amarin shares soar on promising Ph3 triglyceride study. News

> Botched J&J trials trigger $130M award for Basilea. Article 

> GSK boosts Theravance stake after grabbing lead in drug race. Report 

> FDA hands Merck KGaA a new delay on cladribine. Story

> GSK's Witty calls for an R&D renaissance. Item

Biotech IT Report

> India fields FDA-trained trial inspectors. Article

> Team pits Markov chain modeling against melanoma. Item 

> iPhone, iPad found OK for UK health system. News 

> Study probes social media use in regulated industries. Story 

> HP may bump Oracle in software for verticals. Report

> App to make smartphone an STD diagnostic. News

And Finally... A new study shows that heartburn drugs, especially Prilosec, appear to be safe for pregnant women and women who may become pregnant. Report

Suggested Articles

AbbVie and Allergan were already jumping through hoops for their merger before a new tax added hundreds of millions to the cost.

Avastin and Herceptin saw U.S. slowdown that's “not very pronounced” after bioisim launched, but Roche execs still warn of "a significant impact.…

Novo Nordisk, which recently completed a wastewater treatment plant for its massive U.S. API site, has made a gift of the $40 million facility.